SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-188891
Filing Date
2010-08-13
Accepted
2010-08-13 17:00:58
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2010 d10q.htm 10-Q 430623
2 SUMMARY OF NON-EMPLOYEE DIRECTOR CASH COMPENSATION ARRANGEMENTS dex102.htm EX-10.2 2654
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 9635
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9888
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 13A-14(B) OR 15D-14(B) dex321.htm EX-32.1 4928
6 GRAPHIC g88361g86c22.jpg GRAPHIC 10824
  Complete submission text file 0001193125-10-188891.txt   474361
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 101016050
SIC: 2834 Pharmaceutical Preparations